Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Hager A. Elbendary"'
Autor:
Ahmed E. Elsawi, Mai I. Shahin, Hager A. Elbendary, Tarfah Al-Warhi, Fatma E. Hassan, Wagdy M. Eldehna
Publikováno v:
Pharmaceuticals, Vol 17, Iss 1, p 81 (2024)
Targeting the VEGFR-2 signaling pathway is an inveterate approach toward combating pancreatic and hepatocellular cancers. Based on Sunitinib, the FDA-approved VEGFR-2 inhibitor, novel indolin-2-one-triazole hybrids were designed and synthesized as an
Externí odkaz:
https://doaj.org/article/b0471381783149de825651e3784432e9
